Standardization and validation of assays determining cellular immune responses against influenza.

[1]  C. Ewen,et al.  Granzyme B: Correlates with protection and enhanced CTL response to influenza vaccination in older adults. , 2009, Vaccine.

[2]  S. Perk,et al.  A universal epitope-based influenza vaccine and its efficacy against H5N1. , 2009, Vaccine.

[3]  Volker Brauer,et al.  Adjuvanted H5N1 vaccine induces early CD4+ T cell response that predicts long-term persistence of protective antibody levels , 2009, Proceedings of the National Academy of Sciences.

[4]  T. Chotpitayasunondh,et al.  Safety, Humoral and Cell Mediated Immune Responses to Two Formulations of an Inactivated, Split-Virion Influenza A/H5N1 Vaccine in Children , 2008, PloS one.

[5]  J. Farrar,et al.  Memory T cells established by seasonal human influenza A infection cross-react with avian influenza A (H5N1) in healthy individuals. , 2008, The Journal of clinical investigation.

[6]  M. Eichelberger,et al.  FDA/NIH/WHO public workshop on immune correlates of protection against influenza A viruses in support of pandemic vaccine development, Bethesda, Maryland, US, December 10-11, 2007. , 2008, Vaccine.

[7]  S. Plotkin,et al.  Vaccines: correlates of vaccine-induced immunity. , 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[8]  Gavin Giovannoni,et al.  Validating parameters of a luciferase reporter gene assay to measure neutralizing antibodies to IFNbeta in multiple sclerosis patients. , 2008, Journal of immunological methods.

[9]  G. Weverling,et al.  Antibody and T-cell responses to a virosomal adjuvanted H9N2 avian influenza vaccine: impact of distinct additional adjuvants. , 2008, Vaccine.

[10]  Gerhard Walzl,et al.  An Evaluation of Commercial Fluorescent Bead-Based Luminex Cytokine Assays , 2008, PloS one.

[11]  W. Gruber,et al.  Correlation of Cellular Immune Responses with Protection against Culture-Confirmed Influenza Virus in Young Children , 2008, Clinical and Vaccine Immunology.

[12]  R. Rappuoli,et al.  Combination adjuvants for the induction of potent, long-lasting antibody and T-cell responses to influenza vaccine in mice. , 2008, Vaccine.

[13]  Tin Wee Tan,et al.  Evolutionarily Conserved Protein Sequences of Influenza A Viruses, Avian and Human, as Vaccine Targets , 2007, PloS one.

[14]  H. Doerr,et al.  The threat of avian influenza A (H5N1). Part IV: development of vaccines , 2007, Medical Microbiology and Immunology.

[15]  Zoe Moodie,et al.  Optimization and validation of an 8-color intracellular cytokine staining (ICS) assay to quantify antigen-specific T cells induced by vaccination. , 2007, Journal of immunological methods.

[16]  R. G. Das,et al.  Comparison of neutralising antibody assays for detection of antibody to influenza A/H3N2 viruses: an international collaborative study. , 2007, Vaccine.

[17]  Jennifer L. Reed,et al.  Severe Human Lower Respiratory Tract Illness Caused by Respiratory Syncytial Virus and Influenza Virus Is Characterized by the Absence of Pulmonary Cytotoxic Lymphocyte Responses , 2007, The Journal of infectious diseases.

[18]  Cornelia L Dekker,et al.  Humoral and Cellular Immune Responses in Children Given Annual Immunization With Trivalent Inactivated Influenza Vaccine , 2007, The Pediatric infectious disease journal.

[19]  D. Lewis,et al.  Cellular Immune Responses in Children and Adults Receiving Inactivated or Live Attenuated Influenza Vaccines , 2006, Journal of Virology.

[20]  C. Ewen,et al.  T Cell Responses Are Better Correlates of Vaccine Protection in the Elderly1 , 2006, The Journal of Immunology.

[21]  R. Rappuoli,et al.  Oral Spray Immunization May Be an Alternative to Intranasal Vaccine Delivery to Induce Systemic Antibodies but not Nasal Mucosal or Cellular Immunity , 2006, Scandinavian journal of immunology.

[22]  P. Doherty,et al.  Cell-mediated Protection in Influenza Infection , 2006, Emerging infectious diseases.

[23]  M. Altfeld,et al.  Standardization of cytokine flow cytometry assays , 2005, BMC Immunology.

[24]  R. Bleackley,et al.  Comparison of single versus booster dose of influenza vaccination on humoral and cellular immune responses in older adults. , 2005, Vaccine.

[25]  R. Rappuoli,et al.  A Non-Living Nasal Influenza Vaccine Can Induce Major Humoral and Cellular Immune Responses in Humans without the Need for Adjuvants , 2005, Human vaccines.

[26]  E. Bertram,et al.  A novel cytotoxicity assay to evaluate antigen-specific CTL responses using a colorimetric substrate for Granzyme B. , 2003, Journal of immunological methods.

[27]  A. Osterhaus,et al.  Influenza A virus specific T cell immunity in humans during aging. , 2002, Virology.

[28]  R. Webster,et al.  Protective Cross-Reactive Cellular Immunity to Lethal A/Goose/Guangdong/1/96-Like H5N1 Influenza Virus Is Correlated with the Proportion of Pulmonary CD8+ T Cells Expressing Gamma Interferon , 2002, Journal of Virology.

[29]  S. Gravenstein,et al.  Assessment of Markers of the Cell-Mediated Immune Response after Influenza Virus Infection in Frail Older Adults , 1998, Clinical Diagnostic Laboratory Immunology.

[30]  J. Bennink,et al.  Mechanism of protective immunity against influenza virus infection in mice without antibodies. , 1998, Journal of immunology.

[31]  M. Graham,et al.  Resistance to and Recovery from Lethal Influenza Virus Infection in B Lymphocyte–deficient Mice , 1997, The Journal of experimental medicine.

[32]  A. McMichael,et al.  Rapid Effector Function in CD8+ Memory T Cells , 1997, The Journal of experimental medicine.

[33]  T. Croghan,et al.  Transgenic mice lacking class I major histocompatibility complex- restricted T cells have delayed viral clearance and increased mortality after influenza virus challenge , 1992, The Journal of experimental medicine.

[34]  A. McMichael,et al.  Cytotoxic T-cell immunity to influenza. , 1983, The New England journal of medicine.

[35]  J. Bennink,et al.  Generation of both cross-reactive and virus-specific T-cell populations after immunization with serologically distinct influenza A viruses , 1977, The Journal of experimental medicine.

[36]  Masahito Watanabe,et al.  IN MICE , 2009 .

[37]  J. Wood,et al.  Comparison of influenza serological techniques by international collaborative study. , 1994, Vaccine.